Skip to content

Endocan Blood Level in Pulmonary Circulation

Venous Pulmonary Compared to Venous Systemic Blood Level of Endocan During On-pump Cardiac Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04616820
Acronym
ENDOPULM
Enrollment
30
Registered
2020-11-05
Start date
2021-03-31
Completion date
2021-06-30
Last updated
2021-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Cardiopulmonary Bypass, Lung

Keywords

Endocan

Brief summary

Endocan is a proteoglycan produced by the vascular endothelium. Animal studies suggested that the synthesis mainly happen in the pulmonary circulation, but this hypothesis has never been confirmed in humans.

Detailed description

The investigators will measure endocan levels in both pulmonary and systemic venous blood in patients undergoing on pump cardiac surgery. The main objective is to quantify the difference of endocan blood level between the pulmonary and the systemic circulation.

Interventions

None listed

Sponsors

Biothelis
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Planned on pump coronary artery bypass surgery * Non opposition

Exclusion criteria

* Age \< 18 years old * Emergent surgery * Valvular replacement surgery * Combined cardiac surgery * Patients with inflammatory, infectious or evolutive neoplastic pulmonary disease * Patients with valvular problems, in particular aortic insufficiency * Patients who refuse to participate * Legal inability or disability * Patients who will probably not cooperate for the study * Pregnancy and/or breast feeding * Patients not in the Social security system * Patients in the exclusion period of another study

Design outcomes

Primary

MeasureTime frameDescription
Quantify the difference of Endocan blood levels between pulmonary and systemic circulation at the end of cardiopulmonary bypassAt the end of cardiopulmonary bypassBlood samples will be collected at the same time in both pulmonary and systemic circulation at the end of cardiopulmonary bypass to measure Endocan blood level. The primary outcome will be the absolute difference between the Endocan blod level in the pulmonary circulation and in the systemic circulation.

Secondary

MeasureTime frameDescription
Kinetic of Endocan blood level in the systemic circulation during on pump cardiac surgeryPrior to the start of cardiopulmonary bypass, at the beginning and at the end of cardiopulmonary bypass, and at the end of surgeryBlood samples will be collected in the systemic circulation prior to the start of cardiopulmonary bypass, at the beginning of the cardiopulmonary bypass and at the end of cardiopulmonary bypass, and at the end of the surgery

Contacts

Primary ContactGuillaume Besch, MD
gbesch@chu-besancon.fr3 81 21 89 58

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026